Orbimed Advisors - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,690,986
-11.6%
1,244,945
-0.5%
0.44%
+3.8%
Q2 2023$23,395,009
+1.9%
1,251,0700.0%0.42%
-6.0%
Q1 2023$22,957,135
-7.3%
1,251,0700.0%0.45%
-4.9%
Q4 2022$24,771,186
-17.7%
1,251,0700.0%0.47%
-15.2%
Q3 2022$30,101,000
+90.4%
1,251,070
+44.4%
0.56%
+94.8%
Q2 2022$15,812,000
+99.0%
866,396
+139.8%
0.29%
+122.5%
Q1 2022$7,945,000
-0.3%
361,300
+66.5%
0.13%
+26.5%
Q4 2021$7,970,000217,0000.10%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders